ADMA Biologics (ADMA) - News Mentions

Sign up to add (ADMA) to your portfolio and access more historical data.

10%
Est. daily news mentions.

Sign up to access historical data

Sign up

Similar companies

Company News Mentions
Amgen
Amgen
AMGN		 0 100%
Gilead Sciences
Gilead Sciences
GILD		 1 0%
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals
CPRX		 0 0%
Inovio Pharmaceuticals
Inovio Pharmaceuticals
INO		 0 0%
Anavex Life Sciences
Anavex Life Sciences
AVXL		 0 0%
ADMA INVESTIGATION: ADMA Biologics Investors with Losses are Notified to Contact BFA Law about Ongoing Securities Fraud Investigation into Auditor Resignation (Nasdaq:ADMA)
October 31
ADMA Biologics, Inc. (NASDAQ:ADMA) Short Interest Update
October 30
Wall Street Bulls Look Optimistic About Adma Biologics (ADMA): Should You Buy?
October 29
Adma Biologics (ADMA) Exceeds Market Returns: Some Facts to Consider
October 29
ADMA Biologics to Report Third Quarter 2024 Financial Results on November 7, 2024
October 29
ADMA INVESTIGATION NOTICE: ADMA Biologics Stock Plummets 20% after Auditor Resigns; Investors are Notified to Contact BFA Law (Nasdaq:ADMA)
October 29
ADMA Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into ADMA Biologics Inc and Encourages Investors to Contact the Firm
October 29
11,363 Shares in ADMA Biologics, Inc. (NASDAQ:ADMA) Acquired by Highland Capital Management LLC
October 28
ADMA FRAUD ALERT: BFA Law Notifies ADMA Biologics Investors of Ongoing Securities Fraud Investigation after Auditor Resigns and Urges You to Contact the Firm (Nasdaq:ADMA)
October 27
PFG Investments LLC Sells 43,987 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)
October 26
Assenagon Asset Management S.A. Has $69.45 Million Stock Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA)
October 25
ADMA LEGAL NEWS: ADMA Biologics Investigated for Securities Fraud after Stock Drops 20%; Investors with Losses are Urged to Contact BFA Law (Nasdaq:ADMA)
October 25
Grimes & Company Inc. Sells 16,702 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)
October 25
Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA
October 24
ADMA STOCK ALERT: Why is ADMA Biologics being Sued for Securities Fraud? Investors that Lost Money are Notified to Contact BFA Law after Stock Drops 20% (Nasdaq:ADMA)
October 23
Head to Head Contrast: Passage Bio (NASDAQ:PASG) & ADMA Biologics (NASDAQ:ADMA)
October 21

Month over Month

Est. daily news mentions.

Sep 2024 0
Aug 2024 0
Jul 2024 0
Jun 2024 0

How often is ADMA Biologics mentioned in the news?

ADMA Biologics was mentioned an estimated 1 times in online prominent news articles yesterday.

Analyzing News Mentions, how is ADMA Biologics performing compared to its industry peers?

ADMA Biologics underperforms its industry peers when it comes to News Mentions, ranking in the 33rd percentile.

Has there been an increase or decrease in news mentions of ADMA Biologics in the last month?

There has been no significant change in the number of news mentions for ADMA Biologics' compared to the last month.

Why is it important to track news mentions for ADMA Biologics?

By monitoring mentions in the news for ADMA Biologics, investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of ADMA Biologics, ultimately improving their investment strategies.

Sign up and get more insights on ADMA Biologics.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.

Top Stocks

Trending Stocks
Trending Stocks on WallStreetBets
Trending Stocks on Reddit
Top Stocks
Top Stock Performers Today
Bottom Stock Performers Today
Best Airlines Stocks
Best Bank Stocks
Best Semiconductor Stocks
Best Energy Stocks
Best Fintech Stocks
Best Robotics Stocks
Best Insurance Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
Fear & Greed Index
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
House & Congress Trading
Earnings Calendar
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact